Key Points Common meaning BPC-157 plus TB-500 Scientific status Marketing nickname, not a standardised formulation BPC-157 15-residue synthetic peptide TB-500 Seven-residue acetylated thymosin beta-4 fragment Direct stack evidence No robust controlled trial identified Main evidence problem Full thymosin beta-4 research is often mislabelled as TB-500 evidence UK authorisation None identified Sport status Both components prohibited under WADA rules What Is the Wolverine Stack
W., Zhou, X
[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Craft S., Baker L.D., Montine T.J., Minoshima S., Watson G.S., Claxton A., Arbuckle M., Callaghan M., Tsai E., Plymate S.R., et al
S2CID 30725634
Cell population label transfer from single-cell to the spatial transcriptomics data The spatial transcriptomics data underwent quality control using the transcript count and spatial cell size as input
The peptide's gene expression effects offer systemic anti-aging benefits beyond superficial improvements
